Artvigil 250mg Tablet contains Armodafinil 250mg, a prescription wakefulness-promoting medicine. Armodafinil is indicated for improving wakefulness in adults experiencing excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), and shift work disorder (SWD).

Armodafinil tablets are available in strengths including 50mg, 150mg, 200mg, and 250mg. The 250mg strength is therefore a recognized dosage strength of armodafinil.

Product Information

What Is Artvigil 250mg?

Artvigil 250mg is an oral tablet containing 250mg of armodafinil. Armodafinil is used to improve wakefulness in adults with excessive sleepiness associated with specific sleep-related disorders.

Its labeled indications include:

• Narcolepsy
• Obstructive sleep apnea (OSA)
• Shift work disorder (SWD)

For OSA, armodafinil is intended to address excessive sleepiness and does not treat the underlying airway obstruction. Appropriate treatment for the underlying OSA should continue as directed by a healthcare professional.

Artvigil 250mg Uses

Narcolepsy

Armodafinil is indicated to improve wakefulness in adults with excessive sleepiness associated with narcolepsy.

Obstructive Sleep Apnea

Armodafinil may be prescribed to improve excessive sleepiness associated with OSA.

It is important to note that armodafinil does not treat the underlying obstruction. Where CPAP or another treatment is prescribed for the underlying OSA, that treatment should continue according to medical advice.

Shift Work Disorder

Armodafinil is also indicated to improve wakefulness in adults with excessive sleepiness associated with shift work disorder.

How Does Artvigil 250mg Work?

Artvigil contains armodafinil, a wakefulness-promoting agent that acts on the central nervous system.

The precise mechanism responsible for the wakefulness-promoting effects of armodafinil has not been completely established. It is the R-enantiomer of modafinil and is pharmacologically related to modafinil.

Artvigil 250mg Dosage

Artvigil 250mg should be used only according to the prescription provided by a qualified healthcare professional.

The prescribing information for armodafinil states:

Thus, 250mg is within the labeled dosage range for narcolepsy and OSA, but a higher dose is not automatically appropriate for every patient. The prescribing information notes that, in OSA, there is no consistent evidence that doses up to 250mg/day provide additional benefit beyond 150mg/day.

Patients should not change their dose or dosing schedule without medical advice.

Patients with severe hepatic impairment require dosage reduction, while lower doses and closer monitoring may be considered in some elderly patients.